Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400086706Phase 4Recruiting
Phase 4, randomised, double-blind trial of oliceridine in postoperative pain (2 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Resting and exercise VAS pain scores. Started Aug 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400086706.